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Knowledge Translation 
Clinical audits demonstrate that there are gaps between research evidence and what occurs in 
current clinical practice for people with dementia. Studies conducted in Australia suggest 
that: health and aged care professionals do not receive sufficient training in dementia care [1]; 
few people with dementia have advance care plans [2] and the number of people in 
residential aged care facilities prescribed antipsychotics is high [3]. The lack of access to 
specialist services in rural and remote areas of Australia creates further challenges in 
delivering consistent evidence based care for people with dementia [4]. Community dwelling 
people with dementia also report substantial unmet needs, with one study conducted in the 
United States finding approximately half of those surveyed reported the need for home safety 
evaluation, general health and medical care, meaningful activities, and advance care planning 
[75]. Most carers surveyed reported that they needed more education about dementia [5]. 
These evidence practice gaps demonstrate opportunities to improve the quality and safety of 
health and aged care services for people with dementia and their carers in Australia. 
One approach commonly used to improve the quality of care is the development of Clinical 
Practice Guidelines. Guidelines synthesise the latest, highest quality research and provide this 
information in a usable format for clinicians [6]. The research evidence is considered by a 
Committee comprising clinical experts, end users and consumers. The committee form 
recommendations for clinical practice based on available evidence. Australia’s National 
Health and Medical Research Council (NHMRC) standards for clinical practice guidelines 
include 54 mandatory requirements that must be met in order for Clinical Practice Guidelines 
to be considered trustworthy [7]. 
In December, 2015, the NHMRC approved the first Clinical Practice Guidelines and 
Principles of Care for People with Dementia. The Guidelines were developed using ADAPTE 
methodology in which high quality existing international Guidelines are adapted for use in a 
local context [8]. The UK’s  National Institute for Health and Care Excellence (NICE) 
Guidelines for dementia, which were published in 2006, were identified as being the most 
recent, high quality Guidelines and thus were the foundation Guidelines adapted for the 
Australian context [9]. An evidence update (involving 17 systematic reviews) was completed 
to ensure that relevant evidence published subsequent to the NICE Guidelines was included. 
In addition, a dedicated search for literature involving people with dementia of Aboriginal 
and Torres Strait Islander or culturally and linguistically diverse backgrounds in Australia 
was undertaken. 
The Clinical Practice Guidelines for Dementia in Australia are intended primarily for medical 
practitioners, nursing and allied health professionals and aged care workers. The Guidelines 
contain 109 recommendations which are relevant to care provided in community, residential 
and hospital settings. Of these recommendations, 29 were evidence based recommendations, 
seven were classified as consensus based recommendations and 73 were practice points. 
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The main implications for policy and practice associated with the Guidelines are detailed 
below.  
Implications for policy 
Several of the recommendations within the Guidelines indicate areas of care that require 
greater consistency, improvements in service provision or increased access to services. For 
example, the Guidelines recommend that people with a possible diagnosis of dementia should 
be offered referral to memory assessment specialists or services for a comprehensive 
assessment. Specialist assessment was recommended in view of evidence suggesting 
improved outcomes for carers after attending a memory assessment service [10]. An 
international study conducted in the Netherlands found that there were no differences in costs 
between memory clinic and primary care management [11]. However, there are often long 
waiting lists in urban areas for these services and access to memory assessment specialists in 
rural and remote areas is limited. Nevertheless the Guideline Adaptation Committee felt that 
all Australians should have access to such services to improve the quality of dementia care. 
Policy makers should consider ways of overcoming barriers to accessing such services.  
Commonwealth government funded Home Care Packages provide people with formal 
supports to remain in their own home and are usually overseen by a health or aged care 
professional who takes on the role of care coordinator. The number of care packages 
available is limited and there are often long waiting lists to access such packages. The 
Guidelines recommend that people with dementia have access to a care coordinator from the 
time of diagnosis. Care coordination is associated with reduced carer impact and is highly 
valued by care recipients [12]. The recommendation for care coordination does not conflict 
with the recent move towards consumer directed care packages, rather it emphasises the 
importance of the person with dementia and their carer having a key contact person.  
Recent times have seen a move towards care aligned with active ageing and restorative care 
philosophies [13]. Most people live with a diagnosis of dementia for years and minimising 
functional decline can enable the person to participate in valued activities for longer and 
delay the need to move to residential care. The Clinical Practice Guidelines recommend that 
exercise should be strongly encouraged and that people living in the community should have 
access to occupational therapy interventions that aim to promote independence and maximise 
engagement in activities. Policymakers should review existing services and ensure that 
people with dementia have the opportunity to access exercise programs and occupational 
therapy programs for people with dementia.   
Families are often the first people to notice the symptoms of dementia. The Clinical Practice 
Guidelines emphasise the importance of involving carers in all aspects of care including 
during the process of diagnosis. It is recommended that carers have access to programs that 
are tailored and delivered in the home. The content should include: individualised strategies 
and building carer skills to overcome specific problems, training in communicating 
effectively, support and information regarding coping strategies and training in the use of 
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meaningful and enjoyable activities to engage the person with dementia. The availability of 
these types of tailored programs is currently limited.   
Finally, the Guidelines suggest that medical practitioners consider prescribing cognitive 
enhancing medications for indications that are not currently listed on the Pharmaceutical 
Benefits Scheme. Recent evidence suggests beneficial effects of acetylcholinesterase 
inhibitors on cognition and activities of daily living in people with Dementia with Lewy 
Bodies, Parkinson’s Disease dementia and vascular dementia [14-18]. Hence, it is 
recommended that prescription of these agents is considered following open discussion with 
the person with dementia of the potential benefits, side effects and out of pocket costs. 
Implications for practice: 
Research studies consistently find a delay between onset of symptoms and diagnosis [19]. 
Yet, there is a strong argument for timely diagnosis in order for the person and their family to 
plan ahead [20]. The Clinical Practice Guidelines recommend that symptoms are explored 
when first reported and are not dismissed as ‘part of ageing’. Testing in primary care settings 
should include: history taking, cognitive and mental state examination with a validated 
instrument, physical examination, medication review, consideration of other causes and a 
basic dementia screen including blood tests. People with a possible diagnosis of dementia 
should be offered referral to memory assessment specialists or services. While structural 
imaging (via CT or MRI) is recommended in most people to exclude other cerebral 
pathologies, routine testing for biomarkers is considered to be premature. Adherence to the 
recommendations for the process of diagnosis will lead to greater consistency in the process 
across Australia. This will ensure that the tests thought to be beneficial are routinely 
conducted and that the costs and burden associated with unnecessary testing are reduced.      
While the NICE Guidelines provided little guidance regarding the way in which medical 
practitioners should communicate the diagnosis of dementia, there was lengthy discussion 
within the Guideline Adaptation Committee regarding this aspect of care. The Committee 
agreed that communication should be clear and that medical practitioners should not withhold 
information based on their own discomfort in conveying the diagnosis. Difficult scenarios, 
such as the rare occasion when the person states they do not wish to know the diagnosis, 
should be managed carefully; the person’s wish not to know should be respected; however, 
the family may require support to manage this situation and consequences (e.g., driving 
cessation) should be addressed.  
One of the most effective ways of improving the quality and safety of dementia care is 
building the skills of health and aged care professionals to provide person centred care and 
communicate effectively with the person with dementia and their carer. High quality studies 
have shown that training is associated with reduced anxiety, agitation and distress in the 
person with dementia (e.g., [21]). Training programs that have been shown to be effective are 
comprehensive, take place over a number of training sessions and are interactive in nature 
(e.g., incorporate role play and case based training). Health and aged care professionals 
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should also use language consistent with Alzheimer’s Australia guide to dementia friendly 
language.  
Symptoms of dementia such as anxiety, agitation and depression can be distressing for the 
person with dementia and their carers and can be difficult to manage. The importance of 
preventing symptoms with person-centred care is highlighted in the Guidelines, as is 
undertaking an assessment of presenting symptoms and using non-pharmacological strategies 
in the first instance. The Guidelines recommend a trial of SSRI antidepressants for people 
with agitation, while noting that the efficacy of antidepressants for the treatment of 
depression in people with dementia is uncertain. Antipsychotics are not usually recommended 
unless the person has severe symptoms causing distress to themselves or others and non-
pharmacological approaches have failed. There was little evidence identified regarding the 
use of intra-muscular agents in emergency situations such as violence, aggression or extreme 
agitation. The Committee recommended that as circumstances vary between settings, local 
evidence based guidelines should be developed addressing management strategies and 
appropriate use of parenteral medications.   
Finally, the Guidelines formed eight specific recommendations regarding care involving 
people from Aboriginal and Torres Strait Islander or culturally and linguistically diverse 
backgrounds. These recommendations reflect the need to involve appropriate representatives 
in new initiatives specifically for these client groups, to involve bilingual, bicultural workers 
and interpreters in care (particularly during assessment, communicating the diagnosis and 
gaining consent) and to ensure that care plans are culturally appropriate. The KICA and 
RUDAS cognitive assessment tools are recommended as options for use in certain 
circumstances.  
In summary, the Guidelines identify a number of key areas in which there is scope to improve 
the safety and quality of care. The Guidelines and the National Framework for Action on 
Dementia should be used to guide dementia care in Australia over the next five years.   
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